Department of Radiology, Division of Radiology, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, Japan.
Department of Radiology, Sagara Hospital, 3-31 Matsubara-cho, Kagoshima city, Kagoshima, Japan.
Breast Cancer. 2021 Nov;28(6):1188-1194. doi: 10.1007/s12282-020-01107-x. Epub 2020 Jul 6.
In April 2018, the national health insurance coverage of MRI-guided vacuum-assisted breast biopsy (VAB) was instituted with the application of the Japan Breast Cancer Society. Although MRI-guided VAB has been considered as a special procedure for a long time, having an access to this procedure should be recommended for facilities performing breast MRI as in Western countries. From now on, relevant societies should make efforts in data collection and quality control of MRI-guided VAB in Japan. We must avoid the following. To delay the early diagnosis of breast cancer in the judgment of an inaccurate indication, perform unnecessary biopsy due to overestimation of diagnosis, and reduce the success rate of MRI-guided VAB with immature techniques. This review explains the current status of MRI-guided VAB in Japan and shares procedure and biopsy data as a future reference from an experienced facility.
2018 年 4 月，日本乳腺癌学会提出申请，将磁共振成像（MRI）引导下真空辅助乳腺活检（VAB）纳入国家医疗保险范围。虽然 MRI 引导下 VAB 长期以来一直被认为是一种特殊的程序，但在西方国家，有进行乳腺 MRI 的设备的情况下，应该建议使用这种程序。从今往后，日本相关学会应该努力收集和控制 MRI 引导下 VAB 的相关数据。我们必须避免以下情况：因不准确的适应证判断而延误乳腺癌的早期诊断，因过度诊断而进行不必要的活检，以及因不成熟的技术而降低 MRI 引导下 VAB 的成功率。这篇综述介绍了日本目前 MRI 引导下 VAB 的现状，并分享了有经验的机构的手术和活检数据，以供将来参考。
